Inc. (Vilotos)

Covid-19

Singapore eDevelopment subsidiary discovers potential medicines to inhibit Covid-19 in peer-reviewed scientific journal

Singapore eDevelopment’s (SeD) wholly-owned subsidiary Impact Biomedical says that its Covid-19 research with Global Research and Discovery Group Sciences (GRDG) was published in the peer-reviewed scientific journal Molecules on June 11.
×